analysis, fast atom mass and infrared spectroscopy, and, finally, 'H, '3C, and two-dimensional nuclear magnetic resonance demonstrated that the biosurfactant consists of a heterogeneous Cl5 fatty acid tail linked to a peptide moiety very similar to that of surfactin, a lipopeptide produced by BaciUus subtilis. Polyclonal antibodies were raised against surfactin and shown to exhibit identical reactivity towards purified JF-2 lipopeptide in competition enzyme-linked immunosorbent assays, thus providing further evidence for the structural similarity of these two compounds. Under optimal conditions, the B. licheniformis JF-2 biosurfactant exhibits a critical micelle concentration of 10 mg/liter and reduces the interfacial teinsion against decane to 6 x lo-3 dyne/cm, which is one of the lowest interfacial tensions ever reported for a microbial surfactant.
Microbial compounds which exhibit pronounced surface activity are classified as biosurfactants. Microbial biosurfactants include a wide variety of surface-and interfacially active compounds, such as glycolipids, lipopeptides, polysaccharide-protein complexes, phospholipids, fatty acids, and neutral lipids (6) . Biosurfactants consist of distinct hydrophilic and hydrophobic moieties. The former can be either ionic or nonionic and consist of mono-, di-, or polysaccharides; carboxylic acids; amino acids; or peptides. The hydrophobic moieties are usually saturated, unsaturated, or hydroxylated fatty acids. Biosurfactants are easily biodegradable and thus are particularly suited for environmental applications such as bioremediation and the dispersion of oil spills (8, (20) (21) (22) .
Among the many classes of biosurfactants, lipopeptides are particularly interesting because of their high surface activities and therapeutic potential. For example, surfactin, a well-studied lipopeptide antibiotic produced by Bacillus subtilis, is not only a very effective biosurfactant (5) but is also an inhibitor of fibrin clotting (1, 3) and cyclic AMP phosphodiesterase (10) .
Bacillus lichenifornis JF-2, isolated from oil-field injection brine (13) , has been shown to be able to grow and produce a very effective biosurfactant under both aerobic and anaerobic conditions at a very wide range of temperatures and in the presence of high concentrations of salts (12, 17) . We have studied the effects of various environmental parameters on the production of the biosurfactant, the formation of fermentation end products, and the growth of B. licheniformis JF-2 in batch cultures (17, 18) . Although it has been speculated that the JF-2 biosurfactant is similar to surfactin from B. subtilis (7, 19) (14) , have been shown to produce lipopeptides with peptide moieties containing C-terminal amino acid residues different from those of surfactin.
In this study, we purified the surface-active compound from B. licheniformis JF-2 to apparent homogeneity. The structure of this compound was characterized by amino acid analysis and various spectroscopic techniques. As part of the characterization studies, we raised polyclonal antibodies against surfactin and showed that they exhibit the same reactivity for the JF-2 surfactant. This result together with amino acid analysis and two-dimensional nuclear magnetic resonance (NMR) data indicated that the peptide sequence of the JF-2 surfactant is identical to that of surfactin. However, the two compounds differ with respect to the composition of their fatty acid tails. In addition to the chemical characterization of the JF-2 lipopeptide, we studied its interfacial properties and found that under optimal conditions the JF-2 lipopeptide is one of the most effective bacterial lipopeptide surfactants known.
MATERUILS AND METHODS
Microorganisms and growth conditions. B. lichenifonnis JF-2 (ATCC 3097) was obtained from the American Type Culture Collection (Rockville, Md.). The bacteria were grown aerobically in a mineral salt medium (13), containing 0.1% (NH4)2SO4, 0.025% MgSO4, 1% (wt/vol) glucose, 0.5% NaCl in 100 mM phosphate buffer (pH 7.0), and 1.0% (vol/vol) trace metals solution, in 2-liter Erlenmeyer flasks with a working volume of 1 liter at 42°C for 15 h. The trace metals solution contained 0.1% (wt/vol) EDTA, 0.3% MnSO4, 0.001% FeSO4, 0.01% CaCl2, 0.01% CoCl2, 0.01% ZnS04, 0.001% CuS04, 0.001% AlK(S04)2, 0.001% H3B04, and 0.001% Na2MoO4 (4). pBondapak C18 column (7.8 by 300 mm) was used at a flow rate of 0.5 ml/min. The A210 of the eluent was monitored.
Characterization. Infrared spectroscopy was performed on a Nicolet 60SXR FT-IR spectrometer. The spectrum was measured in a sample compartment purged for at least half an hour with dry nitrogen before acquiring data, which were measured at a resolution of 4 cm-' and were averaged over 500 scans. Baselines were electronically adjusted to zero absorbance for the measurement of spectral intensities.
For amino acid analysis, the purified biosurfactant was hydrolyzed in 6 M HCl at 105°C for 24 h. The hydrolysate was subjected to an Applied Biosystems 420H Derivatizer/ Analyzer with on-line 130A Separation System and 920A Data Analysis Module (Foster City, Calif.). Norleucine was added in the samples to a final concentration of 500 pM as an internal standard.
Fast atom bombardment-mass spectroscopy (FAB-MS) analysis was performed on a Finnigan TSQ 70 mass spectrometer with an NBA matrix. Mass spectra were collected from 100 to 1,200 AMU. Positive ions were detected. NMR analysis (1H, '3C, COSY, TOCSY, and ROESY NMR) of JF-2 biosurfactant was performed in a Bruker high-field (11.9-T) NMR spectroscope, with 1,2-dideuteriotetrachloroethane (CDCl2CDCl2) (Norell, Landisville, N.J.) as solvent at 348 K.
Production of polyclonal antibodies against surfactin. A total of 2 mg of surfactin (Calbiochem, San Diego, Calif.), dissolved in a 400-,ul mixture of phosphate-buffered saline (PBS) and dimethylformamide (PBS-dimethylformamide mM glycine (11) . The conjugate was dialyzed against PBS overnight and used to immunize rabbits by subcutaneous injection with incomplete Freund's adjuvant (Sigma) on the basis of a standard schedule (2) . Blood samples were collected from the ear vein 10 weeks after immunization (2 weeks after the booster injection). Sera were prepared by centrifuging the blood samples at 5,000 x g for 10 min.
ELISA. Microtiter plates were coated by an overnight incubation at 37°C with a surfactin-ovalbumin conjugate which was prepared in the same procedure as the surfactin-KLH conjugate used for immunization. The plate was then blocked with 3% bovine serum albumin (BSA) in PBS by incubation at 37°C for 3 h. For competition enzyme-linked immunosorbent assays (ELISAs), 50 ,ul of diluted rabbit surfactin-specific serum (1:1,000 in 3% BSA in PBS) and 100 pA of sample were preincubated at 37°C for 2 h. Subsequently, the mixture was transferred to microtiter plates precoated with the surfactin-ovalbumin conjugate and incu- is the A405 of the positive control (colorless), and ANeg is the A405 of the negative control (green).
Interfacial properties. Interfacial tension measurements against decane were performed in a spinning drop interfacial tensiometer (Model 300; University of Texas, Austin). The critical micelle concentration (CMC) was determined by measuring the interfacial tension of the biosurfactant solution following serial dilution. All interfacial tensions were measured against decane. RESULTS Isolation and purification. Interfacial tension measurements indicated that the biosurfactant can be effectively isolated from the cell-free culture supernatant by either acid precipitation or XAD-2 adsorption chromatography. The interfacial tension increased from 0.085 dyne/cm for the cell-free culture to more than 25 dyne/cm for the reneutralized acid precipitation supernatant of the culture. When acid precipitation was used as the first purification step, 250 mg of acid precipitate was obtained per liter of culture after lyophilization. Subsequently, 110 mg of water-soluble material remained after organic extraction. The crude biosurfactant preparation was further separated into five fractions by silica gel chromatography. Only one fraction, which was eluted after 1.8 bed volumes, contained surface active material. Analytical reverse-phase C18 HPLC analysis showed the presence of three major peaks in this material (Fig. 1) . Preparative reverse-phase C18 HPLC was used to isolate three fractions corresponding to the material in each of the three peaks. Interfacial tension measurements indicated that fraction C contained the most surface active compound. At a concentration of 50 mg/liter in fresh medium with 5% NaCl and adjusted to pH 6.0, the material obtained from fractions A, B, and C gave interfacial tensions against decane of 1.317, 1.873, and 0.060 mN/cm, respectively. Material from fraction C was extracted with an equal volume mixture of chloroform and methanol to remove the salt from the HPLC mobile phase. Approximately 25 mg of the highly active compound per liter of culture was obtained. Since the concentration of the surfactant in the fermentation broth is 34 mg/liter, the overall yield is approximately 70%. The purified material gave a single peak in analytical reversephase C18 HPLC (data not shown). Lack of anomalous peaks in proton and carbon NMRs, as discussed below, provides further confirmation of the purity of the biosurfactant. The same yield and final purity were obtained with either acid precipitation or XAD-2 chromatography as the first separa- Chemical structure of the surfactant. Figure 2 shows the infrared spectrum of the JF-2 biosurfactant. Bands characteristic of peptides (wave number 3,430:NH, wave number 1,655:CO, and wave number 1,534:CN) and aliphatic chains (wave number 3,000 to 2,800, CH2 and CH3) were observed, indicating that this compound is a lipopeptide. Also observed was a band corresponding to an ester carbonyl group (wave number 1,730:CO) (17) . Amino acid analysis indicated the presence of four different amino acid residues in the peptide moiety of the biosurfactant. The composition was determined to be glutamic acid:aspartic acid:valine:leucine = 1:1:1:4. The FAB-MS spectrum (Fig. 3) indicated that the biosurfactant has a molecular mass of 1,035 Da.
Proton NMR (Fig. 4) signals for free CONH2, eliminating asparagine and glutamine as possibilities, the identities of the amino acids were confirmed as aspartic acid, glutamic acid, leucine, and valine. An additional low-field signal at 8 5.3 consistent with CHO of the alcohol moiety of an ester (or lactone) was also observed.
Attempts to obtain the sequence of the amino acids by two-dimensional NOE (ROESY) NMR were moderately successful (Fig. 5) . Germinal as well as more distant protonproton relationships were observed in the ROSEY spectrum. These germinal proton-proton relationships, which can be considered as noises in peptide sequencing, were also observed in the TOCSY spectrum (data not shown) and, therefore, can be eliminated from the ROESY spectrum, leaving signals resulting from distant proton-proton relationships. These remaining proton-proton relationships yield the following partial sequences that are the same as those found in surfactin (15) : fatty acid-Glu-Leu, Asp-Leu, and Leu-Leu. On the bases of the composition of the peptide moiety and the molecular weight of the molecule, the lipid chain was determined to be a C15 fatty acid amidated to the N-terminal amine of the peptide. It was obvious that a mixture of normal, anteiso, and isobranched forms were present (CH3 at 8 13.4, 10.7, and 18.7, and ca. 22, respectively) as observed in the carbon spectrum (Fig. 6 ).
Immunoreactivity with surfactin-specific antibodies. In order to further assess the structural similarity in peptide moiety between surfactin and the JF-2 biosurfactant, we determined the immunoreactivities of the JF-2 biosurfactant against antibodies specific to surfactin. Polyclonal antibodies were raised against a surfactin-KLH conjugate prepared by [1-ethyl-3-(dimethylamino) propyl]-carbodiimide (EDC) coupling. Conjugation of the surfactin to KLH was necessary because surfactin (molecular weight, 1,035) alone is probably too small to elicit an immune response in rabbits. With the surfactin-KLH conjugate, high antibody titers were obtained. Sera were collected and used to develop an ELISA for surfactin. The ELISA analysis showed that the polyclonal antibodies bound to the surfactin-ovalbumin conjugate but not to ovalbumin alone, indicating that they are specific for the surfactin moiety of the surfactin-KLH conjugate (data not shown).
A competition ELISA was developed to demonstrate that the polyclonal antibodies can bind free surfactin molecules. Detection by direct ELISA was not possible because free surfactin molecules could not be applied effectively as a coating to microtiter plate wells, presumably because of the amphiphilic nature of the surfactin. In competition ELISA, a surfactin-containing sample is first preincubated with the polyclonal antibodies and then the mixture is transferred to microtiter wells coated with a surfactin-ovalbumin conjugate. The formation of antigen-antibody complexes during preincubation decreases the amount of free antibodies that can bind to surfactin-ovalbumin. The decreased amount of bound antibodies reduces the signal resulting when the 12 washed plates are incubated with the secondary antibodies. The results of the competition ELISA are shown in Fig. 7 . The absence of any color response, resulting from the complete blocking of the antigen binding sites on antibodies by free surfactin molecules in the preincubation mixture in row D, indicated that the polyclonal antibodies specifically recognize free surfactin. The absence of a decrease in color response in control with SDS (50mg/liter in PBS) in row B indicated that (i) the serum does not react nonspecifically with other surface active compounds and (ii) the lack of color response when the sera were preincubated with surfactin was not due to the detergent character of the molecule causing the desorption of the bound antigen from the wells. We found that the cyclic conformation of the peptide moiety is important for antibody binding since no 
Preincubation of the serum with a solution of the JF-2 surfactant serially diluted twofold from an initial concentration of 25 mg/liter gave an inhibition pattern identical to that obtained with surfactin (Fig. 7, row C) . The percent inhibition by surfactin and the JF-2 biosurfactant at different concentrations is shown in Fig. 8 . It is evident that the percent inhibition is identical, indicating that the surfactinspecific antibodies recognize and exhibit the same affinity for the JF-2 lipopeptide.
Interfacial activity. The effect of pH on the interfacial activity of the JF-2 biosurfactant against decane was investigated. As shown in Fig. 9 , the biosurfactant preparation exhibited optimal interfacial activity at pH 6.0. The interfacial tensions of the solutions at pH 6.0 (0.006 and 0.023 dyne/cm in the presence of 5 and 0.5% of NaCl, respectively) were 10 times lower than those at pH 7.0 with the same ionic strength (0.060 and 0.024 dyne/cm in the presence of 5 and 0.5% of NaCl, respectively). At pH 6.0, the interfacial tension in the presence of 5% NaCl (0.006 dyne/cm) was four licheniformis JF-2. The interfacial tension against decane for solutions of purified biosurfactant resuspended at a concentration of 50 mg/liter in fresh medium with 0.5% NaCl at pH 6.0 (A), fresh medium with 5% NaCl at pH 6.0 (B), the supernatant of acid precipitation with 0.5% NaCl at pH 6.0 (C), and the supernatant of acid precipitation with 5% NaCl at pH 6.0 (D) were measured.
times lower than that in the presence of 0.5% NaCl (0.023 dyne/cm). A similar profile of pH effect on surfactin interfacial activity was also observed (data not shown). Interfacial tension measurements at each dilution of biosurfactant in freshly prepared medium with 0.5% NaCl at pH 6.0 indicated that the biosurfactant has a CMC of 10 mg/liter.
The effects of various additives on the interfacial activity of the biosurfactant are shown in Fig. 10 . For these experiments, the interfacial activity of the biosurfactant was arbitrarily defined as the reciprocal of interfacial tension against decane. The activity of the JF-2 biosurfactant resuspended in the supernatant of acid-precipitated fermentation broth containing 5% NaCl was almost 20 times higher than that of the biosurfactant in freshly prepared growth medium with 0.5% NaCl. This result indicates that both NaCl and acidsoluble components in the fermentation broth function as cosurfactants to augment the interfacial activity of the JF-2 lipopeptide. The interfacial tension of solution containing the JF-2 biosurfactant in the supernatant of acid-precipitated fermentation broth with 5% NaCl at pH 6.0 at a concentration of 50 mg/liter was as low as 0.006 dyne/cm.
DISCUSSION
We have purified the B. licheniformis JF-2 lipopeptide by either acid precipitation or XAD-2 adsorption chromatography as the first step followed by silica gel chromatography and preparative-scale C18 reverse-phase HPLC. These procedures gave about 25 mg of homogeneous material, as determined by analytical HPLC and NMR, with an overall yield of 70%.
The results of chemical analysis, immunological reactivity, and NMR spectra indicate that the chemical structure of the peptide moiety of the JF-2 surfactant is very similar to that of surfactin from B. subtilis. However, some differences between these two biosurfactants were detected. First showed that sodium chloride and metabolites in the culture supernatant work synergistically with the JF-2 biosurfactant in reaching the maximum interfacial activity. Under optimal conditions, JF-2 biosurfactant at a concentration of 50 mg/ liter reduced the interfacial tension of aqueous phase against decane to 0.006 dyne/cm, a 500-fold reduction from the interfacial tension obtained in the absence of surfactant (32 dyne/cm). This is the lowest value that has been reported for microbial surfactant so far (6).
